Introduction
============

Atherosclerosis in the ascending or the proximal thoracic aorta is an independent risk factor for secondary stroke (Acarturk et al., [@B1]; Jones et al., [@B14]; Cardenas, [@B3]; The French Study of Aortic Plaques in Stroke Group, [@B20]; Cohen et al., [@B6],[@B7]; Castellanos et al., [@B4]; Amanuallah et al., [@B2]; Zaidat et al., [@B24]) The risk is related to the shape and characteristics of the aortic plaque and its thickness as measured in millimeters (mm) (Jones et al., [@B14]; The French Study of Aortic Plaques in Stroke Group, [@B20]; Zaidat et al., [@B24]) The estimated relative risk of future stroke in patients with more than 4 mm aortic atheroma (AA) ranges between 1.6 and 4.3 (Acarturk et al., [@B1]; Jones et al., [@B14]; Cardenas, [@B3]; The French Study of Aortic Plaques in Stroke Group, [@B20]; Cohen et al., [@B6]; Castellanos et al., [@B4]; Amanuallah et al., [@B2]; Zaidat et al., [@B24]) The aim of this study is to provide exploratory data on whether the initial stroke severity and/or the clinical 3-month disability outcome can be correlated with the presence or absence of AA as detected on cardiac-gated chest tomography (CGCT). We have shown in our prior studies that the newer and faster multi-slice CT scanners and techniques provide reliable information about AA in patients presenting with acute ischemic stroke when compared to transesophageal echocardiography (TEE) and as part of the same project we prospectively designed this current study to correlate the presence of AA with stroke severity and 3-month clinical outcome (Costello et al., [@B8]; Chung et al., [@B5]; Fuchs et al., [@B11]; Flohr et al., [@B10]; Roos et al., [@B18]; Zaidat et al., [@B25], [@B26]). CGCT is cardiac cycle gated (to limit the motion artifact) and ultrafast (only a single breath hold to complete the actual study). CGCT was found to delineate AA features and detect smaller plaques in higher proportions of patients than TEE (Costello et al., [@B8]; Acarturk et al., [@B1]; Cardenas, [@B3]; Chung et al., [@B5]; Cohen et al., [@B6],[@B7]; Castellanos et al., [@B4]; Amanuallah et al., [@B2]; Roos et al., [@B18]; Zaidat et al., [@B24],[@B25]) thus it was chosen to evaluate for AA.

Materials and Methods
=====================

Patients with acute ischemic stroke, who were admitted to University Hospital of Cleveland, a tertiary medical center, between February and November of 2000 were identified. Of this cohort, patients who underwent CGCT to evaluate AA were selected. Over the interval of the study, there were no consistent guidelines for the use of CGCT in looking for the etiology of ischemic stroke. The CGCT procedure was selected for the patients who had technically inadequate TEE studies, or for those in whom TEE had been unrevealing. To assess for a selection bias, the study sample was compared to the remaining patients with TEE procedures who did not have CGCT.

Selection criteria
------------------

1.  Adult 18 years or older.

2.  Acute ischemic stroke diagnosed by a stroke neurologist.

3.  Completed CGCT for the purpose of evaluating AA.

Exclusion criteria
------------------

1.  Stroke patients who did not undergo the CGCT.

2.  Patients who could not complete the CGCT.

3.  The image quality was not adequate for reliable interpretation.

Study outcomes
--------------

The explanatory variable was the presence or absence of AA on the CGCT and the response variables were stroke severity at presentation and 3-month outcome. The initial stroke severity was assessed using the National Institute of Health Stroke Severity Scale (NIHSS). The NIHSS is routinely recorded in ischemic stroke patients admitted to our institution. The NIHSS was dichotomized to less or equal to 6 points for mild and moderate to severe stroke.

The second clinical outcome of interest is the 3-month modified Rankin disability scale (modified Rankin Scale, mRS). The mRS ranges between 0 and 6, where 0 represents normal function without any residual deficit following a stroke and 6 indicates death. The mRS was dichotomized to 0--1 and 2--6 for good and bad outcomes, respectively.

Statistical analysis
--------------------

The statistical analyses were performed using SPSS V11.0.1 (2001, SPSS Inc.), JMP V3 (SAS Institute, Cary, NC, USA, 1995), and Analyse-it (by Analyse-It Software Inc., England, UK, 2002).

Descriptive statistics
----------------------

Demographics, clinical, and imaging baseline data were presented in a table format, giving the mean with standard deviations (*M* ± SD) and median with inter-quartile ranges. For categorical variables, frequencies, proportions, and percentages were provided. Student's two sample *t*-tests were used to compare the continuous normally distributed data with unequal variances. Fisher's exact test and chi-square were used to compare the proportions among the binary variables. Level of significance was selected at the conventional and standard type I error of α ≤ 0.05.

Outcome analysis
----------------

Associations between atheroma presence and stroke severity as estimated by NIHSS, or of atheroma presence and 3-month mRS were examined using multiple logistic regression to adjust for other known stroke risk factors, including: age, sex, race, hypertension (HTN), diabetes (DM), smoking, and coronary artery disease (CAD). To allow adjustment for other covariates, several models were built with up to five covariates in each model in accordance with parsimonies rule. Factors known to be associated with stroke severity at presentation were included to adjust for confounders or effect modifiers. Prior to incorporating these factors into the model, a univariate analysis was performed to asses the relation of the baseline variables and AA (independent variable) to initial Stroke Severity (response variable).

Variables were incorporated in the model if they were deemed clinically significant or had a *p*-value of \<0.5 on the univariate analysis. We allowed for a large *p*-value because of the sample size and the nature of the exploratory analysis. Regression coefficients were estimated using the maximum likelihood. Goodness of fit was assessed using the likelihood ratio test with chi-square statistics between the full and reduced models. Co-linearity between covariates were assessed by scatter plots and comparing the regression models with and without the variable of interest.

Due to the small sample size, there was limited ability to adjust for other covariates simultaneously using the standard logistic regression, and propensity score (PS) analysis was used to confirm the findings. The PS technique was implemented to incorporate all baseline variables into one continuous score based on the probability of having AA. The PS is the probability between 0 and 1 for a subject to have atheroma present given all his baseline variables, and is estimated using standard logistic regression. The PS model was evaluated for its ability to discriminate between subjects who had atheromas and those who did not, using the area under the receiver operating characteristic (ROC) curve (C Statistic). After calculating the probability for every patient, the PS was incorporated in the regression model as a continuous covariate in addition to the AA to adjust for confounders (Joffe and Rosenbaum, [@B13]).

Results
=======

A total of 32 patients were found to have undergone CGCT for the purpose of evaluating stroke etiology.

Aortic Atheroma and initial stroke severity
-------------------------------------------

There were 21 patients with AA on CGCT, 7 with NIHSS ≤6 and 14 with NIHSS \>6 (*p* = 0.03). The univariate analysis revealed association of these baseline variables with a *p*-value of less than 0.5 (a larger *p*-value was used due to the small sample size) when analyzed against NIHSS: age, ethnicity, HTN, DM, CAD, hyperlipidemia, AA thickness, and smoking (see Table [1](#T1){ref-type="table"}). CAD, AA thickness, large atheroma \>4 mm (consistent with the standard in the literature of what is thought to be significant atheroma thickness), and atheroma presence were associated with worse initial stroke on univariate analysis (*p*-value \<0.05). Multiple logistic regression with NIHSS \>6 as the response variable and looking at the effect of age, CAD, presence or absence of AA, and PS (weighted variable of baseline characteristics according to univariate result) was performed. This multivariate analysis model showed that AA has a slight trend, but no statistical significance, with ischemic stroke presenting with an initial NIHSS \>6 (*p* = 0.08, OR 3.08, 95% CI 0.94--13.52), as shown in Table [2](#T2){ref-type="table"}.

###### 

**Univariate analysis of the baseline features and initial stroke severity (*n*, %, or *M* (±SD)**.

  Variables                      Total: *N* = 32   NIHSS ≤ 6; *N* = 15   NIHSS \> 6; *N* = 17   *p*
  ------------------------------ ----------------- --------------------- ---------------------- ------
  Atheroma (mm)                  3.1 ± 2.4         4.5 ± 2.3             2.5 ± 2.4              0.03
  Any atheroma                   21 (65.6%)        7/15 (46.7%)          14/17 (82.4%)          0.03
  AA \> 4 mm as per literature   15 (46.9%)        4 (26.7%)             11 (64.7%)             0.04
  AA calcification               18 (56.3%)        6 (0.4%)              12 (70.5%)             0.08
  AA protrusion                  11 (34.4%)        3 (20%)               8 (64.7%)              0.15
  AA ulceration                  11 (34.4%)        3 (20%)               8 (64.7%)              0.15
  Age, years, *M* ± SD           66.7 ± 13.9       62 ± 17.7             71 ± 3.3               0.09
  **ETHNICITY**                                                                                 
  White                          26 (81%)          11 (73.3%)            15 (88.3%)             0.28
  Black                          6 (19%)           4 (26.7%)             2 (11.8%)              
  **GENDER**                                                                                    
  Female                         17 (53%)          8 (53.3%)             9 (53%)                0.99
  Male                           15 (47%)          7 (46.7%)             8 (47%)                
  Hypertension                   20 (62.5%)        7 (46.7%)             13 (76.5%)             0.08
  Diabetes                       10 (31.3%)        3 (20%)               7 (41.2%)              0.27
  Hyperlipidemia                 12 (37.5%)        3 (20%)               9 (53%)                0.08
  CAD                            10 (31.3%)        1 (6.7%)              9 (53%)                0.01
  PVD                            8 (25%)           3 (20%)               5 (29.4%)              0.70
  Smoking                        10 (31.3%)        3 (20%)               7 (42.2%)              0.27

*CAD*, *coronary artery disease*; *PVD*, *peripheral vascular disease*.

###### 

**The final model with AA and propensity score adjustment (response: NIHSS (\>6)**.

  Term                     Estimate    Prob \> chi-square   Odds ratio   Lower 95%   Upper 95%
  ------------------------ ----------- -------------------- ------------ ----------- -----------
  Intercept                1.91        0.59                                          
  Age                      −0.08       0.29                 0.01         0.77        1.05
  CAD \[0--1\]             1.59        0.03                 23.89        1.41        27.54
  Propensity score \[1\]   4.81        0.06                 14.58        1.63        33.31
  **CT--AA \[0--1\]**      **1.125**   **0.08**             **3.08**     **0.94**    **13.52**

Aortic atheroma and 3-month clinical stroke outcome
---------------------------------------------------

On the univariate analyses correlating AA with 3-month disability outcome as measured by mRS; the following variables had a *p*-value of less than or equal to 0.5 (low power analysis due to sample size): age, any AA, HTN, DM, hyperlipidemia, and CAD (Table [3](#T3){ref-type="table"}). Standard logistic regression analysis was performed using those variables to predict 3-month stroke outcome dichotomized at ≤1 mRS. A multiple logistic regression analysis model using the functional outcome as response and the effect of AA presence or absence, CAD, age, and PS was performed. PS was used as a weighted variable to adjust for all baseline variables that may be associated with AA. The final model including AA, age, CAD, and PS revealed no association between 3-month mRS and AA presence (*p* = 0.38, OR 0.77, 95% CI 0.4--11.31; see Table [4](#T4){ref-type="table"}).

###### 

**Univariate analysis of the baseline characteristics and 3-month outcome (*n*, %, or *M*(±SD)**.

  Variables               Total: *N* = 32   mRS ≤ 1; *n* = 18   mRS \> 1; *n* = 14   *p*
  ----------------------- ----------------- ------------------- -------------------- -------
  NIHSS \> 6              17/32 (53.1%)     5/18 (27.8%)        12/14 (85.7%)        0.002
  Atheroma (mm)           3.1 ± 2.4         3.2 ± 2.5           3.9 ± 2.4            0.4
  Any atheroma            21 (65.6%)        10 (55.5%)          11 (78.6%)           0.27
  AA \> 4 mm              15 (46.9%)        6 (33.3%)           9 (64.3%)            0.15
  AA calcification        18 (56.3%)        9 (50%)             9 (64.3%)            0.49
  AA protrusion           11 (34.4%)        5 (27.8%)           6 (42.9%)            0.47
  AA ulceration           11 (34.4%)        6 (33.3%)           5 (35.7%)            0.68
  Age, years (*M* ± SD)   66.7 ± 13.9       62.5 ± 15.6         72.5 ± 8.6           0.05
  **ETHNICITY**                                                                      
  White                   26 (81%)          15 (83.3%)          11 (78.6%)           0.68
  Black                   6 (19%)           3 (16.7%)           3 (21.4%)            
  **GENDER**                                                                         
  Female                  17 (53%)          10 (55.5%)          7 (50%)              0.99
  Male                    15 (47%)          8 (44.4%)           7 (50%)              
  Hypertension            20 (62.5%)        9 (50%)             11 (78.6%)           0.15
  Diabetes                10 (31.3%)        2 (11.1%)           8 (57.1%)            0.01
  Hyperlipidemia          12 (37.5%)        6 (33.3%)           6 (42.9%)            0.54
  CAD                     10 (31.3%)        2 (11.1%)           8 (57.1%)            0.01
  PVD                     8 (25%)           5 (27.8%)           3 (21.4%)            0.80
  Smoking                 10 (31.3%)        5 (27.8%)           5 (35.7%)            0.71

###### 

**Logistic regression model with propensity score and AA: response functional outcome (modified Rankin Scale)**.

  Term               Estimate    Prob \> chi-square   Odds ratio   Lower 95%   Upper 95%
  ------------------ ----------- -------------------- ------------ ----------- -----------
  Intercept          −1.59       0.62                                          
  **CT--AA**         −**0.25**   **0.38**             **0.77**     **0.4**     **11.31**
  CAD \[0--1\]       1.28        0.08                 12.83        1           22.13
  Age                0.032       0.54                 7.38         0.93        11.17
  Propensity score   1.47        0.02                 18.96        4.39        21.48

Discussion
==========

The principal goal of this investigation was to explore a potential association between "AA presence and thickness" and the severity of the neurological deficit at the onset of ischemic stroke. It has been difficult to correlate stroke severity with the extent of atherosclerotic change in pre-cerebral blood vessels (Timsit et al., [@B21]; Mitusch et al., [@B16]; Ferrari et al., [@B9]; Geraci and Weinberger, [@B12]; Paciaroni et al., [@B17]; Sen et al., [@B19]; Weinberger et al., [@B23]; Viguier et al., [@B22]; Matsumura et al., [@B15]).

Studies of carotid artery atherosclerosis did not find a simple correlation between stroke severity and degree of stenosis (Timsit et al., [@B21]; Mitusch et al., [@B16]; Ferrari et al., [@B9]; Geraci and Weinberger, [@B12]; Paciaroni et al., [@B17]; Sen et al., [@B19]; Weinberger et al., [@B23]; Viguier et al., [@B22]; Matsumura et al., [@B15]). One study found a correlation between worsened stroke severity and certain morphological features of carotid artery plaque, but not the degree of luminal narrowing (Paciaroni et al., [@B17]). There were higher incidences of death and major disabling stroke with "unstable" plaque, and features including ulceration, irregularities, and mobile protruding atheromas (Paciaroni et al., [@B17]). The possible correlation between AA and stroke severity has not been described previously. One study had shown a higher proportion of medium size subcortical strokes in patients with AA (Matsumura et al., [@B15]). Other studies have also shown increased risk of stroke severity when complex AA features are present (Weinberger et al., [@B23]; Zaidat et al., [@B26]). Our results indicate that AA presence on CGCT may be associated with worse initial stroke severity, the effect was less pronounced after adjusting for baseline covariates by applying a logistic regression model.

To explore the correlation of AA with stroke outcome, we also looked at the association of AA with clinical outcome at 3-month after stroke (mRS), since the latter may bare a higher quality of life and health care impact than the initial stroke severity. Our findings showed that the plaque thickness was not associated with worse outcome at 3 months as was hypothesized, after adjusting for the baseline covariates using standard logistic regression and the PS (*p* = 0.38). This may be related to good patient recovery despite having suffered from severe stroke at presentation.

Our preliminary study is limited by the small sample size. Adjusting for confounding and interaction was not feasible due to the limited number of covariates that can be incorporated in the multivariate model. Applying a PS strengthened the study and allowed for adjustment for the observed but not the hidden bias.

In conclusion; the presence of AA may be associated with worse clinical severity at presentation. These findings need to be confirmed with TEE and spiral CT for stroke types and stroke severity in larger prospective stroke trials.
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